Houston, TX, United States of America

Gregor Eichele

This inventor holds 8 USPTO granted patents. Top assignees: The Salk Institute, Baylor College of Medicine, Ligand Pharmaceuticals, Inc.. Active years: 1999-2006.


% Patents Active = 87.5

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1999-2006

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gregor Eichele

Introduction

Gregor Eichele, an accomplished inventor based in Houston, TX, has made significant strides in the realm of biological sciences with a focus on retinoid receptors. With a remarkable portfolio of eight patents, his work has influenced numerous fields, particularly in understanding and modulating metabolic processes.

Latest Patents

Among his latest patents is a notable invention titled "Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor." This innovative method presents high-affinity, high-specificity ligands designed to interact with retinoid receptors. One aspect of this invention includes the development of rexoids, ligands that exhibit increased selectivity for the retinoid X receptor compared to retinoic acid. Additionally, Eichele has unveiled alternative ligands capable of inducing processes mediated by retinoic acid receptors, along with methods for synthesizing these novel ligands from common compounds. Another critical patent involves a method for modulating lipid metabolism through the administration of 9-cis retinoic acid, highlighting its specificity for the retinoid X receptor.

Career Highlights

Gregor Eichele's career has been marked by his association with esteemed institutions, including the Salk Institute for Biological Studies and Baylor College of Medicine. His research and inventions reflect a deep commitment to advancing our understanding of complex biological processes, paving the way for new therapeutic approaches.

Collaborations

Throughout his career, Eichele has collaborated with leading scientists in the field, including Ronald Mark Evans and David John Mangelsdorf. These partnerships have played a crucial role in his research, fostering innovation and expanding the impact of his work on retinoid receptors.

Conclusion

Gregor Eichele stands as a prominent figure in the landscape of modern inventors, with a rich legacy of patents that contribute to the fields of biology and medicine. His vision and dedication to discovering new methods for modulating biological processes continue to inspire future innovations and advancements in the scientific community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…